Navigation Links
ISCAR, world-wide conference on role of culture in human development, convenes at UCSD
Date:9/3/2008

The Second Congress of the International Society for Cultural and Activity Research (ISCAR) will take place at the University of California, San Diego, Sept. 8-13, 2008. Nearly 1,000 researchers from 40 countries will attend the conference with others participating from around the globe via state-of-the-art telecommunications.

The Society's members are researchers interested in the social, cultural and historical dimensions of human practices where the context, or environment, is seen as of paramount importance. The congress theme, "Ecologies of Diversities," refers to the variety of settings and, human experiences therein, upon which ISCAR members focus. More information is available at the Congress website (http://iscar2008.com/).

Congress President, Olga Vsquez, associate professor of communication at UC San Diego, provided a window into some of the conference sessions: "We will have more than 240 workshops and presentations on diverse topics such as the study of community mobilization approaches to HIV/AIDS in South Africa, cultural modeling in African American communities, and local power construction in a school for socially marginalized students in Mexican rural communities."

Presenters will offer perspectives from multiple academic fields in the social sciences, education, and humanities focusing on activities and cultural practices that support human learning and development in the home, classroom, work space, streets and in the virtual worlds of communication and information technologies. Among the disciplines represented are psychology, education, philosophy, history, sociology, linguistics, anthropology, work research, computer sciences, information systems, knowledge management, clinical neuropsychology and rehabilitation, occupational therapy, criminology, and social work.

State-of-the-art technology, provided by UC San Diego division of the California Institute for Telecommunications and Information Technology (
'/>"/>

Contact: Barry Jagoda
bjagoda@ucsd.edu
858-534-8567
University of California - San Diego
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Carnegie Mellon to host micromanufacturing conference
2. Abaxis, Inc. CEO to Present at the Eighth Annual Forbes Global CEO Conference in Singapore
3. InterMune to Present at Thomas Weisel Partners Healthcare Conference
4. ISTA Pharmaceuticals to Present at the Thomas Weisel Partners Healthcare Conference 2008
5. Zimmer Holdings to Present at Thomas Weisel Partners Conference
6. Aflac Incorporated To Present at the Keefe, Bruyette & Woods 2008 Insurance Conference
7. AMICAS to Present at Thomas Weisel Partners Healthcare Conference 2008
8. Lilly and Amylin Set Date and Time for Conference Call
9. AtriCure to Participate at the Thomas Weisel Partners Healthcare Conference and the UBS Global Life Sciences Conference in September
10. Pharmacy Technician Certification Board (PTCB) Exhibits at 2008 NACDS Pharmacy & Technology Conference
11. HMS Holdings Corp. to Present at Thomas Weisel Partners 2008 Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 2GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 3GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 4GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 5GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 6Hill-Rom Introduces Innovative Smart Bed for Medical-Surgical Settings 2Hill-Rom Introduces Innovative Smart Bed for Medical-Surgical Settings 3Hill-Rom Introduces Innovative Smart Bed for Medical-Surgical Settings 4CVS Caremark Names New Chief Human Resources Officer 2Emerson Ecologics Introduces the Emerson Quality Partner 28TM 29 Program 55830 1Emerson Ecologics Introduces the Emerson Quality Partner 28TM 29 Program 55830 2Archi Tech Closes the Gap Between Pharmaceutical Managed Care and Primary Sales with Pull Through Reporting Capabilities 55826 1Archi Tech Closes the Gap Between Pharmaceutical Managed Care and Primary Sales with Pull Through Reporting Capabilities 55826 2NOVAVAX Announces Positive Results for the Second Phase II Clinical Trial of its Trivalent Seasonal Influenza Virus like Particle 28VLP 29 Vaccine Ca 13759 1NOVAVAX Announces Positive Results for the Second Phase II Clinical Trial of its Trivalent Seasonal Influenza Virus like Particle 28VLP 29 Vaccine Ca 13759 2NOVAVAX Announces Positive Results for the Second Phase II Clinical Trial of its Trivalent Seasonal Influenza Virus like Particle 28VLP 29 Vaccine Ca 13759 3NOVAVAX Announces Positive Results for the Second Phase II Clinical Trial of its Trivalent Seasonal Influenza Virus like Particle 28VLP 29 Vaccine Ca 13759 4NOVAVAX Announces Positive Results for the Second Phase II Clinical Trial of its Trivalent Seasonal Influenza Virus like Particle 28VLP 29 Vaccine Ca 13759 5
Other Medicine Technology:Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 2Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 3Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 4Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 5Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 2Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 3Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 4Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 5Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 6Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 7